These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


130 related items for PubMed ID: 6236317

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Blood serum and urine levels of fibrin fibrinogen degradation products in kidney diseases].
    Kacprzyk F, Orłowski Z.
    Pol Tyg Lek; 1980 Mar 31; 35(13):461-3. PubMed ID: 7393746
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Intraglomerular coagulation in patients with glomerulonephritis, with special reference to FDP D-dimer].
    Shibata T, Ura S, Hirai Y, Taura K, Harada T, Hara K.
    Nihon Naika Gakkai Zasshi; 1983 Sep 31; 72(9):1143-9. PubMed ID: 6663183
    [No Abstract] [Full Text] [Related]

  • 9. [Significance of urinary fibrin/fibrinogen degradation product (FDP) D-dimer measured by highly sensitive ELISA method with a new monoclonal antibody (D-D E72) in various renal diseases].
    Shibata T, Magari Y, Mizunaga S, Okabe E, Sumie A, Ishii T, Tomo T, Yasumori R, Nasu M.
    Nihon Jinzo Gakkai Shi; 1994 Jul 31; 36(7):805-12. PubMed ID: 8072218
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Effect of urokinase therapy in patients with glomerulonephritis and nephrotic syndrome. Trial at multiple institutes in Japan].
    Tomura S, Takeuchi J, Tanaka K.
    Nihon Jinzo Gakkai Shi; 1984 Jan 31; 26(1):97-121. PubMed ID: 6376892
    [No Abstract] [Full Text] [Related]

  • 17. [Urinary cross-linked FDP in various renal diseases].
    Inuma H.
    Nihon Jinzo Gakkai Shi; 1994 Feb 31; 36(2):146-57. PubMed ID: 8139147
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Clinical observations on renal vein blood fibrin degradation products (FDP) in glomerulonephritis (author's transl)].
    Tomura S.
    Nihon Jinzo Gakkai Shi; 1979 May 31; 21(3):233-44. PubMed ID: 470233
    [No Abstract] [Full Text] [Related]

  • 20. [Studies on molecular markers for hemostasis and thrombosis in various renal diseases].
    Shibata T, Ishii T, Tomo T, Kaneko K, Nasu M, Magari Y, Fukushima K.
    Nihon Jinzo Gakkai Shi; 1991 Apr 31; 33(4):373-8. PubMed ID: 1831516
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.